Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Simeoni

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Pharmaceutical Research|September 27, 2018
Population Pharmacokinetic Modelling for Estimation of Remifentanil Metabolic-Ratio Using Non-steady-State Concentrations under Rapidly Adaptive DosingMonica Simeoni, Chao Chen
Clinical Pharmacology and Therapeutics|March 10, 2022
Longitudinal Model-Based Meta-Analysis of Lung Function Response to Support Phase III Study Design in Chinese Patients With AsthmaShuying Yang, Monica Simeoni, Misba Beerahee
Computer Methods and Programs in Biomedicine|March 12, 2004
Validation of two algorithms to evaluate the interface between bone and orthopaedic implantsDebora Testi, Monica Simeoni, Cinzia Zannoni, et al.
Computer Methods and Programs in Biomedicine|January 1, 2003
An automated method to position prosthetic components within multiple anatomical spacesMarco Viceconti, Debora Testi, Monica Simeoni, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 29, 2024
Longitudinal modeling of efficacy response in patients with lupus nephritis receiving belimumabMonica Simeoni, Shuying Yang, Debra J Tompson, et al.
Drug Discovery Today. Technologies|September 21, 2013
Modeling of human tumor xenografts and dose rationale in oncologyMonica Simeoni, Giuseppe De Nicolao, Paolo Magni, et al.
Stroke|March 9, 2013
Safety, pharmacokinetics, and pharmacodynamics of escalating repeat doses of GSK249320 in patients with strokeSteven C Cramer, Bams Abila, Nicola E Scott, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Modeling Alzheimer's disease progression using the disease system analysis approachRoberto Gomeni, Monica Simeoni, Marina Zvartau-Hind, et al.
Stroke|February 24, 2017
Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke PatientsSteven C Cramer, Lori A Enney, Colleen K Russell, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2018
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issuesSilvia Maria Lavezzi, Enrica Mezzalana, Stefano Zamuner, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pharmaceutical Research|September 27, 2018
Population Pharmacokinetic Modelling for Estimation of Remifentanil Metabolic-Ratio Using Non-steady-State Concentrations under Rapidly Adaptive DosingMonica Simeoni, Chao Chen
Clinical Pharmacology and Therapeutics|March 10, 2022
Longitudinal Model-Based Meta-Analysis of Lung Function Response to Support Phase III Study Design in Chinese Patients With AsthmaShuying Yang, Monica Simeoni, Misba Beerahee
Computer Methods and Programs in Biomedicine|March 12, 2004
Validation of two algorithms to evaluate the interface between bone and orthopaedic implantsDebora Testi, Monica Simeoni, Cinzia Zannoni, et al.
Computer Methods and Programs in Biomedicine|January 1, 2003
An automated method to position prosthetic components within multiple anatomical spacesMarco Viceconti, Debora Testi, Monica Simeoni, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 29, 2024
Longitudinal modeling of efficacy response in patients with lupus nephritis receiving belimumabMonica Simeoni, Shuying Yang, Debra J Tompson, et al.
Drug Discovery Today. Technologies|September 21, 2013
Modeling of human tumor xenografts and dose rationale in oncologyMonica Simeoni, Giuseppe De Nicolao, Paolo Magni, et al.
Stroke|March 9, 2013
Safety, pharmacokinetics, and pharmacodynamics of escalating repeat doses of GSK249320 in patients with strokeSteven C Cramer, Bams Abila, Nicola E Scott, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Modeling Alzheimer's disease progression using the disease system analysis approachRoberto Gomeni, Monica Simeoni, Marina Zvartau-Hind, et al.
Stroke|February 24, 2017
Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke PatientsSteven C Cramer, Lori A Enney, Colleen K Russell, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2018
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issuesSilvia Maria Lavezzi, Enrica Mezzalana, Stefano Zamuner, et al.
Pageof 2